Learn more about the ways in which $120 million in new funding will help us meet a growing demand for our automated microbial detection platform while continuing to support biopharmaceutical companies that must operate with reduced staff during the COVID-19 pandemic.
Our vision is to be the trusted standard in microbiology automation. Growth Direct
helps us fulfill that vision by creating operational efficiencies that enable our customers
to deliver essential healthcare products. Only Growth Direct offers so many distinct advantages:
Innovative technology >
Ensures data integrity >
Increases efficiency >
Streamlines quality >
Effective risk management >
"Growth Direct is a game changer for QC microbial testing. It lets us report, review, and respond faster than ever. The validated automation and data migration capabilities are invaluable for optimizing resources and ensuring data integrity."
Bill Carpenter, QC Microbiology, Biogen